AETHLON MEDICAL INC AEMD

$6.05 +0.67% at last close
Market Cap$4.30 million
P/E Ratio—
Div Yield—
Volume15.2K
52-Week Range $1.41$41.35

Key Stats

Today's Range
$6.03 – $6.18
50-Day Range
$1.41 – $9.50
52-Week Range
$1.41 – $41.35
Volume
15K shs
Average Volume
4.86 million shs
Market Cap
$4.30 million
P/E Ratio
—
Dividend Yield
—

Short Interest

Short Interest
176.25%
Days to Cover
3.47

About AETHLON MEDICAL INC

Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.

Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees
9
Exchange
XNAS
Listed
1998-11-06

Related Stocks

Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.